iBio Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Details)

Stockholders' Equity (Details) - USD ($)																				1 Months Ended								3 Months Ended	6 Months Ended	8 Months Ended	12 Months Ended
Stockholders' Equity (Details) - USD ($)	Jun. 30, 2020	Jun. 30, 2020	Jun. 17, 2020	May 13, 2020	Mar. 19, 2020	Mar. 13, 2020	Oct. 29, 2019	Oct. 28, 2019	Mar. 19, 2019	Jul. 12, 2018	Jul. 12, 2018	Jun. 28, 2018	Jun. 26, 2018	Nov. 27, 2017	Feb. 23, 2017	Apr. 13, 2016	Apr. 07, 2016	Jan. 25, 2016	Jan. 13, 2016	Jul. 31, 2020	Jul. 27, 2020	Jun. 30, 2020	Nov. 30, 2018	Jun. 26, 2018	Jun. 26, 2018	May 31, 2018	Feb. 23, 2017	Oct. 13, 2020	Dec. 31, 2019	Jun. 30, 2020	Jun. 30, 2020	Jun. 30, 2019	Feb. 20, 2020	Jun. 30, 2018	Jun. 20, 2018	Mar. 31, 2018	Nov. 30, 2017	Dec. 31, 2015
Stockholders' Equity [Line Items]
Preferred Stock, Shares Authorized	1,000,000	1,000,000													1,000,000							1,000,000					1,000,000			1,000,000	1,000,000	1,000,000
Stock Issued During Period, Value, New Issues							$ 4,500,000																		$ 16,000,000							$ 0
Preferred Stock, Par or Stated Value Per Share													$ 1,000											$ 1,000	$ 1,000										$ 0.001
Shares Issued, Price Per Share													$ 0.90											0.90	$ 0.90
Issuance of common stock to underwriters (in shares)													4,350,000												4,350,000
Warrants to purchase shares of Common Stock																													14,999,998				9,595,002
Proceeds from the exercise of warrants																														$ 6,400,000	$ 6,330,000	0
Shares of common stock issued for the cashless exercise of Warrants																														5,900,000
Cashless exercise of warrants reducing balance owed for notes payable - warrant exchange																														$ 1,300,000	$ 1,305,000	$ 0
Costs related to the warrant exchange offset against additional paid-in capital																														$ 313,000
Warrants outstanding	0	0																				0								0	0
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001																				$ 0.001								$ 0.001	$ 0.001	$ 0.001
Common Stock, Shares Authorized	275,000,000	275,000,000																				275,000,000								275,000,000	275,000,000	275,000,000
Common Stock, Capital Shares Reserved for Future Issuance																																3,517,000
Proceeds from Issuance of Common Stock							$ 4,520,000
Common Stock, Shares, Issued	140,071,110	140,071,110																				140,071,110								140,071,110	140,071,110	20,152,458
Share Price	$ 2.22	$ 2.22																				$ 2.22								$ 2.22	$ 2.22	$ 0.71		$ 0.90
Underwriting Discounts, Commissions and Other Offering Expenses										$ 159,000															$ 854,000
No sales period													90 days
Underwriting option period													45 days
Proceeds from Warrant Exercises																														$ 6,400,000	$ 6,330,000	$ 0
Proceeds from Noncontrolling Interests																							$ 2,459,000			$ 1,093,000
Stock Issued During Period, Shares, Warrants Exercised																														29,100,000
Sale of Stock, Consideration Received on Transaction													$ 16,000,000
Cost for issuance of shares																															$ 2,170,000	$ 159,000
Series A Warrants [Member]
Stockholders' Equity [Line Items]
Issuance of common stock to underwriters (in shares)							25,000,000																						3,300,000
Class of Warrant or Right, Exercise Price of Warrants or Rights							$ 0.22
Number of stocks sold							1
Exercise price of warrants							$ 0.22
Term of the warrants							2 years
Series B Warrants [Member]
Stockholders' Equity [Line Items]
Issuance of common stock to underwriters (in shares)							25,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights							$ 0.22
Number of stocks sold							1
Exercise price of warrants							$ 0.22
Term of the warrants							7 years
Stock Issued During Period, Shares, Warrants Exercised																													6,600,000
Common Stock [Member]
Stockholders' Equity [Line Items]
Convertible Preferred Stock, Shares Issued upon Conversion																																5,887,997
Stock Issued During Period, Value, New Issues																																$ 1,000
Shares Issued, Price Per Share													$ 0.90											$ 0.90	$ 0.90
Issuance of common stock to underwriters (in shares)							2,450,000																									142,000
Conversion of Stock, Shares Issued							22,550,000
Shares, Outstanding	140,071,000	140,071,000																				140,071,000								140,071,000	140,071,000	20,152,000		16,040,000
Number of stock issued on each unit of stock sold							1
Stock Issued During Period, Shares, Warrants Exercised																															35,000,000
Preferred Stock [Member]
Stockholders' Equity [Line Items]
Preferred Stock, Shares Authorized	1,000,000	1,000,000																				1,000,000								1,000,000	1,000,000
Stock Issued During Period, Value, New Issues																																$ 0
Issuance of common stock to underwriters (in shares)																																0
Shares, Outstanding	6,000	6,000																				6,000								6,000	6,000	10,000		12,000
Stock Issued During Period, Shares, Warrants Exercised																															0
Warrant [Member]
Stockholders' Equity [Line Items]
Number of stocks sold							2
Common Stock and Warrants [Member]
Stockholders' Equity [Line Items]
Shares Issued, Price Per Share							$ 0.20
Preferred Tracking Stock [Member]
Stockholders' Equity [Line Items]
Convertible Preferred Stock, Shares Issued upon Conversion																																				29,990,000
Stock Issued During Period, Shares, Acquisitions															1
Preferred Stock, Dividends Per Share, Declared																															$ 0
Series A Preferred Stock [Member]
Stockholders' Equity [Line Items]
Preferred Stock, Shares Authorized	6,300	6,300																				6,300								6,300	6,300	6,300			1,000,000
Preferred Stock, Par or Stated Value Per Share																																			$ 0.001
Convertible Preferred Stock, Terms of Conversion																															Each share of Series A Preferred is convertible into an amount of shares of common stock determined by dividing the stated value of $1,000 by the conversion price in effect at such time. The original conversion price of $0.90 was adjusted to $0.20 upon the closing of the Company's public offering on October 29, 2019. See the sections below entitled "Public Offering – June 26, 2018" and "Public Offering – October 29, 2019" for further information. The number of shares of common stock to be received is limited by the beneficial ownership limitation as defined in the certificate of designation. Subject to limited exceptions, a holder of Series A Preferred would not have the right to exercise any portion of its Series A Preferred if such holder, together with its affiliates, would beneficially own over 4.99% of the number of shares of our common stock outstanding immediately after giving effect to such exercise; provided, however, that upon 61 days' prior notice to us, such holder may increase the such limitation, provided that in no event will the limitation exceed 9.99%.
Conversion of Stock, Shares Converted																																2,223
Issuance of common stock to underwriters (in shares)													6,300											6,300
Shares, Outstanding	0	0																				0								0	0	3,987
Share Price													$ 1,000											$ 1,000	1,000									$ 0.20
Series A Preferred Stock [Member] \| Common Stock [Member]
Stockholders' Equity [Line Items]
Conversion of Stock, Shares Converted																																2,470,000
Series B Preferred Stock [Member]
Stockholders' Equity [Line Items]
Preferred Stock, Shares Authorized	5,785	5,785																				5,785								5,785	5,785	5,785			1,000,000
Stock Issued During Period, Value, New Issues													$ 5,785
Convertible Preferred Stock, Terms of Conversion																															Each share of Series B Preferred is convertible into an amount of shares of common stock determined by dividing the stated value of $1,000 by the conversion price in effect at such time. The original conversion price of $0.90 was adjusted to $0.20 upon the closing of the Company's public offering on October 29, 2019. See the sections below entitled "Public Offering - June 26, 2018" and "Public Offering - October 29, 2019" for further information. The number of shares of common stock to be received is limited by the beneficial ownership limitation as defined in the certificate of designation. Subject to limited exceptions, a holder of Series B Preferred will not have the right to exercise any portion of its Series B Preferred if such holder, together with its affiliates, would beneficially own over 48% of the number of shares of common stock outstanding immediately after giving effect to such exercise.
Conversion of Stock, Shares Converted																															28,925,000
Shares Issued, Price Per Share							$ 0.20
Issuance of common stock to underwriters (in shares)													5,785
Dividends Payable	$ 0	$ 0																				$ 0								$ 0	$ 0
Common Stock, Capital Shares Reserved for Future Issuance	28,925,000	28,925,000																				28,925,000								28,925,000	28,925,000
Shares, Outstanding	5,785.00	5,785.00																				5,785.00								5,785.00	5,785.00	5,785.00
Share Price													$ 1,000											$ 1,000	$ 1,000
Stock Issued During Period, Shares, Other													5,785
Series C Preferred Stock [Member]
Stockholders' Equity [Line Items]
Preferred Stock, Shares Authorized								1,000,000
Preferred Stock, Par or Stated Value Per Share								$ 0.001
Convertible Preferred Stock, Terms of Conversion																															Each share of Series C Preferred was convertible into an amount of shares of common stock determined by dividing the stated value of $1,000 by the conversion price of $0.20, subject to adjustment. The number of shares of common stock to be received was limited by the beneficial ownership limitation as defined in the certificate of designation. Subject to limited exceptions, a holder of Series C Preferred would not have the right to exercise any portion of its Series C Preferred if such holder, together with its affiliates, would beneficially own over 4.99% (or, upon election by a holder prior to the issuance of any Series C Preferred Shares, 9.99%) of the number of shares of our Common Stock outstanding immediately after giving effect to such exercise; provided, however, that upon prior notice to us, such holder may increase such limitation, provided that in no event will the limitation exceed 9.99% and any such increase would not be effective until the 61st day after such notice was delivered to the Company
Shares Issued, Price Per Share								$ 0.20
Maximum Common Stock Percentage								4.99%
Issuance of common stock to underwriters (in shares)							4,510
Dividends Payable								$ 0.00
Common Stock, Par or Stated Value Per Share	$ 1,000.000	$ 1,000.000						$ 1,000														$ 1,000.000								$ 1,000.000	$ 1,000.000	$ 1,000.000
Maximum ownership through conversion without prior notice, prior to the issuance of preferred shares								9.99%
Common Stock, Shares Authorized	4,510	4,510																				4,510								4,510	4,510	4,510
Common Stock, Shares, Issued	0	0																				0								0	0	0
Series C Preferred Shares, and Warrants [Member]
Stockholders' Equity [Line Items]
Shares Issued, Price Per Share							$ 1,000
Over-Allotment Option [Member]
Stockholders' Equity [Line Items]
Stock Issued During Period, Value, New Issues											$ 1,350,000
Shares Issued, Price Per Share										$ 0.90	$ 0.90
Issuance of common stock to underwriters (in shares)											1,500,000
Proceeds from Issuance of Common Stock										$ 1,350,000
Sale Of Stock Number Of Shares Offered For Sale																									2,666,666
Underwritten offering
Stockholders' Equity [Line Items]
Proceeds from Issuance of Common Stock							$ 5,000,000
Eastern Share Purchase Agreements [Member]
Stockholders' Equity [Line Items]
Stock Issued During Period, Value, New Issues																$ 4,043,000		$ 2,177,000
Shares Issued, Price Per Share																			$ 6.22
Term of agreement												2 years
Maximum Common Stock Percentage														38.00%		38.00%
Issuance of common stock to underwriters (in shares)																650,000	650,000		650,000
Proceeds from the exercise of warrants																			$ 945,000
Stock Issued During Period, Shares, Acquisitions																			350,000
Equity Method Investment, Ownership Percentage																																					40.00%
Agreement term												2 years
Class Of Warrants Or Rights Exercised																		178,400
Proceeds from Warrant Exercises																			$ 945,000
Eastern Affiliate [Member]
Stockholders' Equity [Line Items]
Maximum Common Stock Percentage												48.00%
Issuance of common stock to underwriters (in shares)												650,000
Equity Method Investment, Ownership Percentage																			40.00%
Preferred Tracking Stock [Member]
Stockholders' Equity [Line Items]
Convertible Preferred Stock, Shares Issued upon Conversion															29,990,000												29,990,000
Stock Issued During Period, Value, New Issues															$ 13,000,000												$ 13,000,000
Preferred Stock, Dividend Rate, Percentage																															2.00%
Dividends Payable	$ 871,000	$ 871,000																				$ 871,000								$ 871,000	$ 871,000	$ 610,000
UBS Securities, LLC ("UBS")
Stockholders' Equity [Line Items]
Issuance of common stock to underwriters (in shares)	17,400,000
Proceeds from Issuance of Common Stock	$ 37,800,000
Sale of Stock, Consideration Received on Transaction			$ 72,000,000
Commission rate			3.00%
Reimbursement of fees and disbursements			$ 50,000
Cost for issuance of shares	$ 1,270,000
UBS Securities, LLC ("UBS") \| Common Stock [Member]
Stockholders' Equity [Line Items]
Issuance of common stock to underwriters (in shares)																						2,400,000						8,600,000
Net Proceeds From Issuance Of Common Stock																						$ 5,550,000						$ 24,600,000
Ibio CMO [Member]
Stockholders' Equity [Line Items]
Noncontrolling Interest, Ownership Percentage by Parent															99.99%												99.99%											100.00%
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners																			70.00%
Preferred Stock, Par or Stated Value Per Share															$ 0.001												$ 0.001
Shares exchanged for ownership interest																			29,990,000
Ibio CMO [Member] \| Preferred Tracking Stock [Member]
Stockholders' Equity [Line Items]
Noncontrolling Interest, Amount Represented by Preferred Stock															$ 13,000,000												$ 13,000,000
Ibio CMO [Member] \| Preferred tracking stock issued in exchange of units [Member]
Stockholders' Equity [Line Items]
Noncontrolling Interest, Ownership Percentage by Parent															99.99%												99.99%
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners															0.01%												0.01%
Ibio CMO [Member] \| Preferred tracking stock issued in exchange of units [Member] \| Preferred Tracking Stock [Member]
Stockholders' Equity [Line Items]
Shares exchanged for ownership interest															29,990,000
Ibio CMO [Member] \| Preferred tracking stock exchanged for units [Member]
Stockholders' Equity [Line Items]
Noncontrolling Interest, Ownership Percentage by Parent	70.00%	70.00%																				70.00%								70.00%	70.00%
Ibio CMO [Member] \| Preferred tracking stock exchanged for units [Member] \| Preferred Tracking Stock [Member]
Stockholders' Equity [Line Items]
Shares exchanged for ownership interest															29,990,000
Ibio CMO [Member] \| Eastern Affiliate [Member]
Stockholders' Equity [Line Items]
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners															0.01%												0.01%
Ibio CMO [Member] \| Eastern Affiliate [Member] \| Preferred tracking stock exchanged for units [Member]
Stockholders' Equity [Line Items]
Noncontrolling Interest, Ownership Percentage by Parent															70.00%												70.00%
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners	30.00%	30.00%													30.00%							30.00%					30.00%			30.00%	30.00%
Ibio CDMO [Member] \| Eastern Affiliate [Member]
Stockholders' Equity [Line Items]
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners															0.01%												0.01%
Lincoln Park 2020 Purchase Agreement
Stockholders' Equity [Line Items]
Stock Issued During Period, Value, New Issues						$ 1,100,000
Shares Issued, Price Per Share						$ 1.09
Term of agreement					36 months				36 months
Maximum obligation under each Regular Purchase					$ 5,000,000
Floor price					$ 0.20
Maximum Common Stock Percentage					19.99%
Issuance of common stock to underwriters (in shares)		16,800,000			815,827	1,000,000																									16,800,000
Maximum ownership through conversion without prior notice					9.99%
Proceeds from Issuance of Common Stock		$ 18,400,000							$ 50,000,000																						$ 18,400,000
Aggregate Common Stock Purchased					$ 50,000,000
Agreement term					36 months				36 months
Sale Of Stock Number Of Shares Offered For Sale					1,000,000
Net Proceeds From Issuance Of Common Stock																															$ 42,200,000
Lincoln Park 2020 Purchase Agreement \| Subsequent event
Stockholders' Equity [Line Items]
Issuance of common stock to underwriters (in shares)																				2,700,000	2,670,000
Proceeds from Issuance of Common Stock																				$ 6,800,000	$ 6,790,000
Net Proceeds From Issuance Of Common Stock																				$ 24,600,000
Securities and Exchange Commission \| Lincoln Park May 2020 Purchase Agreement
Stockholders' Equity [Line Items]
Stock Issued During Period, Value, New Issues				$ 1,090,000
Shares Issued, Price Per Share				$ 1.09
Issuance of common stock to underwriters (in shares)				1,000,000